Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Endocarditis: basics.

× No keyword cloud information.

7 in total

1. Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases.

Authors: C C Lamas; S J Eykyn
Journal: Clin Infect Dis Date: 1997-09 Impact factor: 9.079

2. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study.

Authors: O Korzeniowski; M A Sande
Journal: Ann Intern Med Date: 1982-10 Impact factor: 25.391

Review 3. Infective endocarditis, dentistry and antibiotic prophylaxis; time for a rethink?

Authors: R A Seymour; R Lowry; J M Whitworth; M V Martin
Journal: Br Dent J Date: 2000-12-09 Impact factor: 1.626

4. Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin.

Authors: W R Wilson; R L Thompson; C J Wilkowske; J A Washington; E R Giuliani; J E Geraci
Journal: JAMA Date: 1981 Jan 23-30 Impact factor: 56.272

5. Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study.

Authors: B L Strom; E Abrutyn; J A Berlin; J L Kinman; R S Feldman; P D Stolley; M E Levison; O M Korzeniowski; D Kaye
Journal: Ann Intern Med Date: 1998-11-15 Impact factor: 25.391

6. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.

Authors: D T Durack; A S Lukes; D K Bright
Journal: Am J Med Date: 1994-03 Impact factor: 4.965

7. Fever during treatment of infective endocarditis.

Authors: A Douglas; J Moore-Gillon; S Eykyn
Journal: Lancet Date: 1986-06-14 Impact factor: 79.321

7 in total

12 in total

1. Transforming growth factor-beta(1) expression in dilated cardiomyopathy.

Authors: J E Sanderson; K B Lai; I O Shum; S Wei; L T Chow
Journal: Heart Date: 2001-12 Impact factor: 5.994

2. Idiopathic dilated cardiomyopathy: lack of association with haemochromatosis gene in the CARDIGENE study.

Authors: G Hetet; B Grandchamp; C Bouchier; V Nicaud; L Tiret; G Roizès; M Desnos; K Schwartz; R Dorent; M Komajda
Journal: Heart Date: 2001-12 Impact factor: 5.994

3. Contrast enhanced magnetic resonance angiography and pulmonary venous anomalies.

Authors: F Godart; S Willoteaux; C Rey; B Cocheteux; C Francart; J P Beregi
Journal: Heart Date: 2001-12 Impact factor: 5.994

4. Effects of cardiac resynchronisation on maximal and submaximal exercise performance in advanced heart failure patients with conduction abnormality.

Authors: D Birnie; L P Soucie; S Smith; A S Tang
Journal: Heart Date: 2001-12 Impact factor: 5.994

Endocarditis: basics.

1. Suggested modifications to the Duke criteria for the clinical diagnosis of native valve and prosthetic valve endocarditis: analysis of 118 pathologically proven cases.

2. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study.

Review 3. Infective endocarditis, dentistry and antibiotic prophylaxis; time for a rethink?

4. Short-term therapy for streptococcal infective endocarditis. Combined intramuscular administration of penicillin and streptomycin.

5. Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study.

6. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.

7. Fever during treatment of infective endocarditis.

1. Transforming growth factor-beta(1) expression in dilated cardiomyopathy.

2. Idiopathic dilated cardiomyopathy: lack of association with haemochromatosis gene in the CARDIGENE study.

3. Contrast enhanced magnetic resonance angiography and pulmonary venous anomalies.

4. Effects of cardiac resynchronisation on maximal and submaximal exercise performance in advanced heart failure patients with conduction abnormality.

5. Reciprocal increase of circulating interleukin-10 and interleukin-6 in patients with acute myocardial infarction.

6. Percutaneous aortic valve replacement: will we get there?

7. Tetrahydrobiopterin attenuates cholesterol induced coronary hyperreactivity to endothelin.

Review 8. Valve disease: Surgery of valve disease: late results and late complications.

9. Native quadruple-valve endocarditis caused by Enterococcus faecalis.

10. Identification of protein candidates for the serodiagnosis of Q fever endocarditis by an immunoproteomic approach.